Status:
RECRUITING
The Utility of Thromboelastography in Traumatic Brain Injury
Lead Sponsor:
Shanghai 6th People's Hospital
Conditions:
Traumatic Brain Injury
Coagulation Disorder
Eligibility:
All Genders
18-80 years
Brief Summary
Hemocoagulation disorder is recognized to have crucial effects on hemorrhagic or ischemic diseases. Coagulation-related damages secondary to traumatic brain injury are common and severe secondary insu...
Eligibility Criteria
Inclusion
- Patients who are delivered to hospital within 24 hours after head trauma
- Patients whose abbreviated injury score (AIS) for other body regions is 3 or less are considered to be isolated traumatic brain injury
Exclusion
- Patients with existing prior neurological disease
- Patients with known coagulation disorders
- Patients on anticoagulants and medications known to affect coagulation function within 30 days before trauma
- Patients receiving blood components prior to blood draw
- Patients who deteriorate and die before determining whether coagulation- related damage exists
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04524637
Start Date
September 1 2018
End Date
December 31 2027
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Sixth People's Hospital
Shanghai, China, 200233